Setting IOP Targets
The Setting IOP Targets module covers the rationale for setting target intraocular pressure and outlines data from important glaucoma clinical trials with their implications for patient management.
Reducing the intraocular pressure (IOP) level is an important goal when treating patients with glaucoma, as several clinical trials have shown that most glaucoma-induced damage is pressure-dependent.
Keeping IOP in check benefits patients by protecting the optic nerve from damage and preserving the visual field. However, determining the specific level to which IOP should be lowered to achieve optimal glaucoma management in every patient is a challenge.
The first part of this presentation discusses the rationale behind setting IOP targets and is designed to aid the practising ophthalmologist in establishing an IOP range for each patient that will help preserve vision and quality of life. In-depth evidence from landmark trials in glaucoma, covering major findings that impact clinical care, is reviewed in the second portion of this module.
At the end of the presentation, participating clinicians should be able to:
- understand the importance of establishing and maintaining consistently low target IOP ranges
- list the different treatment categories for glaucoma based on the SEAGIG Asia Pacific Glaucoma Guidelines
- confidently set a target IOP range based on the treatment categories and individual patient factors, and
- describe the outcomes and implications of key clinical trials demonstrating the role of IOP lowering in preventing disease progression.
The final slide lists key take-home messages from the presentation.
Click here to view the Setting IOP Targets Module Download and print (SEAGIG Members only) 
